Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patients

被引:6
作者
Cao, Ya-Li [1 ]
Tian, Zhi-Gang [2 ]
Wang, Fang [3 ]
Li, Wen-Ge [1 ]
Cheng, Dan-Ying [4 ]
Yang, Yan-Fang [1 ]
Gao, Hong-Mei [1 ]
机构
[1] China Japan Friendship Hosp, Dept Nephrol, Beijing 100029, Peoples R China
[2] Beijing Luhe Hosp, Dept Surg, Beijing 101149, Peoples R China
[3] China Japan Friendship Hosp, Dept Gastroenterol, Beijing 100029, Peoples R China
[4] Capital Med Univ, Beijing Ditan Hosp, Dept Hepatol, Beijing 100015, Peoples R China
基金
中国国家自然科学基金;
关键词
Nonsteroidal anti-inflammatory drug; Hepato-nephrotoxicity; Acute interstitial nephritis; Acute hepatitis; Cholestasis; INDUCED LIVER-INJURY; RENAL-FAILURE; HEPATOTOXICITY; EPIDEMIOLOGY; DICLOFENAC; MANAGEMENT; DIAGNOSIS; IBUPROFEN; NSAID;
D O I
10.3748/wjg.v20.i38.13956
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To determine the clinicopathological characteristics of nonsteroidal anti-inflammatory drug (NSAID)induced acute hepato-nephrotoxicity among Chinese patients. METHODS: We conducted a retrospective chart review of patients using the International Classification of Diseases, Ninth Revision diagnosis code for acute kidney injury (AKI) (584.5 or 584.9) and for acute liver injury (ALI) (570.0 or 573.3) from January 2004 to December 2013. Medical records were reviewed to confirm the diagnosis of AKI and ALI and to quantify NSAID administration. RESULTS: Seven of 59 patients (11.8%) were identified with acute hepato-nephrotoxicity induced by NSAIDs. Five patients (71.4%) received over the recommended NSAIDs dose. Compared with NSAIDs-associated mere AKI, the risk factors of NSAIDs-induced acute hepato-nephrotoxicity are age older than 60 years (57.1%), a high prevalence of alcohol use (71.4%) and positive hepatitis B virus (HBV) markers (85.7%). Compared with NSAIDs-associated mere ALI, the risk factors of NSAIDs-induced acute hepato-nephrotoxicity are age older than 60 years (57.1%), increased extracellular volume depletion (71.4%), and renin-angiotensin-aldosterone system (RAAS) inhibitor combined use (57.1%). Acute interstitial nephritis and acute tubulointerstitial disease were apparent in three out of six (42.9%) kidney biopsy patients, respectively. Acute hepatitis was found in four out of six (66.7%) liver biopsy patients. Overall complete recovery occurred in four patients within a mean of 118.25 +/- 55.42 d. CONCLUSION: The injury typically occurred after an overdose of NSAIDs. The risk factors include age older than 60 years, alcohol use, positive HBV markers, extracellular volume depletion and RAAS inhibitor combined use. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:13956 / 13965
页数:10
相关论文
共 34 条
[11]   Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors [J].
Juhlin, T ;
Björkman, S ;
Gunnarsson, B ;
Fyge, A ;
Roth, B ;
Höglund, P .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (07) :909-916
[12]   Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) [J].
Kellum, John A. ;
Lameire, Norbert .
CRITICAL CARE, 2013, 17 (01)
[13]   How Common Is Diclofenac-Associated Liver Injury? Analysis of 17,289 Arthritis Patients in a Long-Term Prospective Clinical Trial [J].
Laine, Loren ;
Goldkind, Lawrence ;
Curtis, Sean P. ;
Connors, Laurine G. ;
Zhang Yanqiong ;
Cannon, Christoper P. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (02) :356-362
[14]   Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011 [J].
Lee, William M. ;
Stravitz, R. Todd ;
Larson, Anne M. .
HEPATOLOGY, 2012, 55 (03) :965-967
[15]   Aggravation of non-steroidal anti-inflammatory drug-induced hepatitis and acute renal failure by slimming drug containing anthraquinones [J].
Li, FK ;
Lai, CK ;
Poon, WT ;
Chan, AYW ;
Chan, KW ;
Tse, KC ;
Chan, TM ;
Lai, KN .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (07) :1916-1917
[16]   Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma? [J].
Lok, Anna Suk-Fong .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (02) :221-227
[17]  
Musu M, 2011, EUR REV MED PHARMACO, V15, P1461
[18]   Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients [J].
Onuigbo, Macaulay A. C. ;
Onuigbo, Nnonyelum T. C. .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (01) :233-239
[19]   An overview of drug-induced acute kidney injury [J].
Pannu, Neesh ;
Nadim, Mitra K. .
CRITICAL CARE MEDICINE, 2008, 36 (04) :S216-S223
[20]   Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III) [J].
Paulose-Ram, R ;
Hirsch, R ;
Dillon, C ;
Losonczy, K ;
Cooper, M ;
Ostchega, Y .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (04) :315-326